Terumo Corporation (4543)

Name: Terumo Corporation (4543) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-10-02

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies.

Dati chiave

Capitalizzazione di mercato: JPY 3.31 trillion
Ricavi (esercizio chiuso a 2026-03-31): JPY 1.13T
Utile netto: JPY 135.9B
Margine lordo: 52.5%
Margine netto: 12.0%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Entrate totali	JPY 1.13T	JPY 1.04T	JPY 921.9B	JPY 820.2B	—
Utile lordo	JPY 594.7B	JPY 560.7B	JPY 479.2B	JPY 417.4B	—
Risultato Operativo (EBIT)	JPY 176.3B	JPY 157.7B	JPY 140.1B	JPY 117.3B	—
Reddito netto	JPY 135.9B	JPY 117.0B	JPY 106.4B	JPY 89.3B	—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 4543. /companies/us/4543

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.